I'm wondering what everyone's opinion is as to the risk profile of CSL. What are the things that could damage the SP and margins?
Forgetting global recessions, trade wars, GFCs etc which affect everything. What specific market and/or company risks does CSL have?
For example, skimming through the Annual Report I would assume certain new drugs not passing trials would be a factor. Is CSL heavily reliant upon certain countries and their laws, which if changed could result in issues?
Before I get too many DYOR replies, understand group discussions are a form of research
CSL risk profile
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.86 |
Change
-0.700(0.23%) |
Mkt cap ! $148.7B | |||
| Open | High | Low | Value | Volume |
| $307.48 | $309.49 | $306.25 | $197.1M | 639.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10435 | $307.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.94 | 817 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |